All type of patients: 12 trials - Rivera - Tabernero - Sedky - Willemse - 304 Study Group - Sjostrom - TXT Group - Bontenbal - Blohmer - Bonneterre - HERNATA - JCOG
| docetaxel vs doxorubicin + cyclophosphamide | No demonstrated result | |
| docetaxel vs fluorouracil, vinorelbine | No demonstrated result | |
| docetaxel vs mitomycin, vinblastine | No demonstrated result | |
| docetaxel vs sequential methotrexate and 5-fluorouracil | No demonstrated result | |
| docetaxel + doxorubicin vs fluorouracil, doxorubicin, cyclophosphamide | No demonstrated result | |
| docetaxel + epirubicin vs epirubicin, cyclophosphamide | No demonstrated result | |
| docetaxel + epirubicin vs fluorouracil, epirubicin, cyclophosphamide | No demonstrated result | |
| docetaxel + trastuzumab vs vinorelbine, trastuzumab | No demonstrated result | |
| Weekly Docetaxel vs Every three weeks Docetaxel | No demonstrated result |
All type of patients: 9 trials - DISTAl 01 (Gridelli) - Camps - Schuette - Gervais - Lai - Chen - TAX 317 (Shepherd) 100mg/m2 - TAX 320 100mg/m2 - Esteban
| docetaxel vs | No demonstrated result | |
| paclitaxel 80mg/m2 vs m2docetaxel 36 mg/ | No demonstrated result | |
| weekly docetaxel vs 3-weekly docetaxel | No demonstrated result |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
